IL-1β promotes malignant transformation and tumor aggressiveness in oral cancer

Journal of Cellular Physiology

Volumn 230, Issue 4, 2015, Pages 875-884

  Lee, Chia Huei ^a   Chang, Jeffrey Shu Ming ^a   Syu, Shih Han ^a   Wong, Thian Sze ^b   Chan, Jimmy Yu Wai ^b   Tang, Ya Chu ^a   Yang, Zhi Ping ^a   Yang, Wen Chan ^a   Chen, Chiung Tong ^a   Lu, Shao Chun ^c   Tang, Pei Hua ^a   Yang, Tzu Ching ^c   Chu, Pei Yi ^d   Hsiao, Jenn Ren ^e   Liu, Ko Jiunn ^a,f,g  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d St Martin De Porres Hospital   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^g NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; ARECOLINE; CARCINOGEN; CYTOKINE ANTIBODY; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; KETONE; NICOTINE; NITROSAMINE; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETEL NUT; CANCER CELL CULTURE; CANCER STAGING; CARCINOGENESIS; CELL PROLIFERATION; CELL STRUCTURE; DISEASE SEVERITY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; INFLAMMATION; KERATINOCYTE; LYMPH NODE METASTASIS; MALIGNANT TRANSFORMATION; METASTASIS; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TOBACCO; UPREGULATION; ANIMAL; CELL CULTURE; CELL TRANSFORMATION; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; MOUSE; MOUTH TUMOR; SQUAMOUS CELL CARCINOMA;

GASTROPODA; NICOTIANA TABACUM; PIPER BETEL;

ANIMALS; ARECOLINE; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-1BETA; KERATINOCYTES; MICE; MOUTH NEOPLASMS;

EID: 84919772748     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24816     Document Type: Article

References (41)

1. Allen IC, TeKippe EM, Woodford RM, Uronis JM, Holl EK, Rogers AB, Herfarth HH, Jobin C, Ting JP. 2010. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med 207:1045-1056.
2. Apte RN, Krelin Y, Song X, Dotan S, Recih E, Elkabets M, Carmi Y, Dvorkin T, White RM, Gayvoronsky L, Segal S, Voronov E. 2006. Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions. Eur J Cancer 42:751-759.
3. Apte RN, Voronov E. 2008. Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? Immunol Rev 222:222-241.
4. Arlt A, Vorndamm J, Muerkoster S, Yu H, Schmidt WE, Folsch UR, Schafer H. 2002. Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines. Cancer Res 62:910-916.
5. Carrozzo M, Uboldi de Capei M, Dametto E, Fasano ME, Arduino P, Broccoletti R, Vezza D, Rendine S, Curtoni ES, Gandolfo S. 2004. Tumor necrosis factor-alpha and interferon-gamma polymorphisms contribute to susceptibility to oral lichen planus. J Invest Dermatol 122:87-94.
6. Chang SE, Foster S, Betts D, Marnock WE. 1992. DOK, a cell line established from human dysplastic oral mucosa, shows a partially transformed non-malignant phenotype. Int J Cancer 52:896-902.
7. Chang NW, Pei RJ, Tseng HC, Yeh KT, Chan HC, Lee MR, Lin C, Hsieh WT, Kao MC, Tsai MH, Lin CF. 2010. Co-treating with arecoline and 4-nitroquinoline 1-oxide to establish a mouse model mimicking oral tumorigenesis. Chem Biol Interact. 183:231-237.
8. Chen LC, Wang LJ, Tsang NM, Ojcius DM, Chen CC, Ouyang CN, Hsueh C, Liang Y, Chang KP, Chen CC, Chang YS. 2012. Tumour inflammasome-derived IL-1beta recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma. EMBO Mol Med 4:1276-1293.
9. Dohadwala M, Wang G, Heinrich E, Luo J, Lau O, Shih H, Munaim Q, Lee G, Hong L, Lai C, Abemayor E, Fishbein MC, Elashoff DA, Dubinett SM, St John MA. 2010. The role of ZEB1 in the inflammation-induced promotion of EMT in HNSCC. Otolaryngology 142:753-759.
10. Estilo CL, Oc P, Talbot S, Socci ND, Carlson DL, Ghossein R, Williams T, Yonekawa Y, Ramanathan Y, Boyle JO, Kraus DH, Patel S, Shaha AR, Wong RJ, Huryn JM, Shah JP, Singh B. 2009. Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer 9:11.
11. Franchi L, Eigenbrod T, Munoz-Planillo R, Nunez G. 2009. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 10:241-247.
12. Furuta H, Osawa K, Shin M, Ishikawa A, Matsuo K, Khan M, Aoki K, Ohya K, Okamoto M, Tominaga K, Takahashi T, Nakanishi O, Jimi E. 2012. Selective inhibition of NF-kappaB suppresses bone invasion by oral squamous cell carcinoma in vivo. Int J Cancer 131:E625-E635.
13. Gandolfo S, Richiardi L, Carrozzo M, Broccoletti R, Carbone M, Pagano M, Vestita C, Rosso S, Merletti F. 2004. Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus: a follow-up study in an Italian population. Oral Oncol 40:77-83.
14. Jeng JH, Wang YJ, Chiang BL, Lee PH, Chan CP, Ho YS, Wang TM, Lee JJ, Hahn LJ, Chang MC. 2003. Roles of keratinocyte inflammation in oral cancer: Regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline. Carcinogenesis 24:1301-1315.
15. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. 1995. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol 24:450-453.
16. Kok SH, Hong CY, Lin SK, Lee JJ, Chiang CP, Kuo MY. 2007. Establishment and characterization of a tumorigenic cell line from areca quid and tobacco smoke-associated buccal carcinoma. Oral Oncol 43:639-647.
17. Lee CH, Ko YC, Huang HL, Chao YY, Tsai CC, Shieh TY, Lin LM. 2003. The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan. Br J Cancer 88:366-372.
18. Lee CH, Wong TS, Chan JY, Lu SC, Lin P, Cheng AJ, Chen YJ, Chang JS, Hsiao SH, Leu YW, Li CI, Hsiao JR, Chang JY. 2013. Epigenetic regulation of the X-linked tumour suppressors BEX1 and LDOC1 in oral squamous cell carcinoma. J Pathol 230:298-309.
19. Li Y, St John MA, Zhou X, Kim Y, Sinha U, Jordan RC, Eisele D, Abemayor E, Elashoff D, Park NH, Wong DT. 2004. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 10:8442-8450.
20. Li Y, Wang L, Pappan L, Galliher-Beckley A, Shi J. 2012. IL-1beta promotes stemness and invasiveness of colon cancer cells through Zeb1 activation. Mol Cancer 11:87.
21. Liao B, Zhong BL, Li Z, Tian XY, Li Y, Li B. 2010. Macrophage migration inhibitory factor contributes angiogenesis by up-regulating IL-8 and correlates with poor prognosis of patients with primary nasopharyngeal carcinoma. J Surg Oncol 102:844-851.
22. Lin WJ, Jiang RS, Wu SH, Chen FJ, Liu SA. 2011. Smoking, alcohol, and betel quid and oral cancer: a prospective cohort study. J Oncol 2011:525976.
23. Lin SC, Liu CJ, Chiu CP, Chang SM, Lu SY, Chen YJ. 2004. Establishment of OC3 oral carcinoma cell line and identification of NF-kappa B activation responses to areca nut extract. J Oral Pathol Med 33:79-86.
24. Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K. 2005. Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation. Oral Surg Oral Med Oral Pathol 100:164-178.
25. Mignogna MD, Fedele S, Lo Russo, Lo L, Muzio L, Bucci E. 2004. Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: Is there any evidence. Oral Oncol 40:120-130.
26. Park JH, Han HJ. 2009. Caveolin-1 plays important role in EGF-induced migration and proliferation of mouse embryonic stem cells: Involvement of PI3K/Akt and ERK. Am J Physiol Cell Physiol 297:C935-C944.
27. Peng CH, Liao CT, Peng SC, Chen YJ, Cheng AJ, Juang JL, Tsai CY, Chen TC, Chuang YJ, Tang CY, Hsieh WP, Yen TC. 2011. A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma. PLoS One. 6: e 23452.
28. Poveda-Roda R, Bagan JV, Jimenez-Soriano Y, Margaix-Munoz M, Sarrion-Perez G. 2010. Changes in smoking habit among patients with a history of oral squamous cell carcinoma (OSCC). Med Oral Patol Oral Cir Bucal 15:e721-e726.
29. Rao SK, Pavicevic Z, Du Z, Kim JG, Fan M, Jiao Y, Rosebush M, Samant S, Gu W, Pfeffer LM, Nosrat CA. 2010. Pro-inflammatory genes as biomarkers and therapeutic targets in oral squamous cell carcinoma. J Biol Chem 285:32512-32521.
30. Rheinwald JG, Beckett MA. 1981. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res 41:1657-1663.
31. Rodstrom PO, Jontell M, Mattsson U, Holmberg E. 2004. Cancer and oral lichen planus in a Swedish population. Oral Oncol 40:131-138.
32. Schroder K, Tschopp J. 2010. The inflammasomes. Cell 140:821-832.
33. Sheu JJ, Lee CC, Hua CH, Li CI, Lai MT, Lee SC, Cheng J, Chen CM, Chan C, Chao SC, Chen JY, Chang JY, Lee CH. 2013. LRIG1 modulates aggressiveness of head and neck cancers by regulating EGFR-MAPK-SPHK1 signaling and extracellular matrix remodeling. Oncogene.
34. Shinriki S, Jono H, Ueda M, Ota K, Ota T, Sueyoshi T, Oike Y, Ibusuki M, Hiraki A, Nakayama H, Shinohara M, Ando Y. 2011. Interleukin-6 signalling regulates vascular endothelial growth factor-C synthesis and lymphangiogenesis in human oral squamous cell carcinoma. J Pathol 225:142-150.
35. Shintani S, Ishikawa T, Nonaka T, Li C, Nakashiro K, Wong DT, Hamakawa H. 2004. Growth-regulated oncogene-1 expression is associated with angiogenesis and lymph node metastasis in human oral cancer. Oncology 66:316-322.
36. Storci G, Sansone P, Mari S, D'Uva G, Tavolari S, Guarnieri T, Taffurelli M, Ceccarelli C, Santini D, Chieco P, Marcu KB, Bonafe M. 2010. TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype. J Cell Physiol 225:682-691.
37. Takamune Y, Ikebe T, Nagano O, Shinohara M. 2008. Involvement of NF-kappaB-mediated maturation of ADAM-17 in the invasion of oral squamous cell carcinoma. Biochem Biophys Res Commun 365:393-398.
38. Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakura Y, Dinarello CA, Apte RN. 2003. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 100:2645-2650.
39. Wen CP, Tsai SP, Cheng TY, Chen CJ, Levy DT, Yang HJ, Eriksen MP. 2005. Uncovering the relation between betel quid chewing and cigarette smoking in Taiwan. Tob Control 14:i16-i22.
40. Yadav A, Kumar B, Datta J, Teknos TN, Kumar P. 2011. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol Cancer Res 9:1658-1667.
41. Zienolddiny S, Ryberg D, Maggini V, Skaug V, Canzian F, Haugen A. 2004. Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer. Int J Cancer 109:353-356.